LA JOLLA, Calif. and CORALVILLE, Iowa – Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and Integrated DNA Technologies, Inc. (IDT), the world leader in production and supply of oligonucleotides, today jointly announced that they have entered into an agreement to manufacture, market, […]
Roche announced today that it has provided notice to Illumina, Inc. (NASDAQ: ILMN) that it will nominate a slate of highly qualified, independent candidates for election to Illumina’s Board of Directors and propose certain other matters for the consideration of Illumina’s shareholders at Illumina’s 2012 annual meeting, which, if adopted, would result in Roche-nominated directors […]
RENO, Nevada and BRANFORD, Connecticut – Hamilton Robotics announced today a new automated solution for DNA sample enrichment on the MICROLAB STARlet Liquid Handling Workstation. Integrating Roche’s REM e liquid handling system, the workflow solution enriches up to eight DNA samples for subsequent sequencing on the GS FLX System [ https://www.454.com/products-solutions/product-list.asp ]. The integrated system […]
FRAMINGHAM, Mass. & TORRANCE, Calif.–Scientists at the AB SCIEX/Phenomenex Rapid Response Unit have developed a method to test orange juice for the presence of a chemical fungicide called Carbendazim, which has been getting media attention in North America in recent weeks. This new method is in response to recent governmental concerns that shipments from Brazil, […]
Uniqsis of Cambridge, UK, and WaveCraft of Uppsala, Sweden, have entered into a collaborative agreement to develop and market a new range of microwave-based flow chemistry systems that will radically improve efficiency when scaling up compound synthesis during drug development. By integrating proven liquid handling technology from Uniqsis with unique microwave applicator technology and reactors […]
SAN DIEGO– Illumina, Inc. (NASDAQ:ILMN) (“the Company”), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today confirmed that Roche (RHHBY.PK) has commenced its previously announced unsolicited tender offer to acquire all of the outstanding shares of Illumina’s common stock for $44.50 per […]
BILLERICA, Mass.–Bruker Corporation and SISCAPA Assay Technologies, Inc. (SAT) today announced the publication of a study in the Journal of Proteome Research (J. Proteome Res., Just Accepted Manuscript, DOI: 10.1021/pr201092v, Publication Date (Web): January 18, 2012) demonstrating that SISCAPA MALDI-TOF mass spectrometry provides excellent precision for quantitation of proteins of interest, such as high value […]
BASEL, Switzerland — Roche today responded to an announcement from Illumina, Inc. ILMN -0.19% that its Board of Directors has adopted a shareholder rights plan. Although not unexpected, Roche is disappointed that the Illumina Board of Directors has been unwilling to participate in substantive discussions with Roche regarding a negotiated transaction and has instead adopted […]
NEW YORK – Swedish firm Addtech Life Science today announced it has acquired BioNordika Holding. Addtech Life Science is a business area in the Addtech Group. BioNordika Holding is the parent company of the BioNordika Group, which markets reagents and instruments for biomedical research, primarily to the pharmaceutical industry and public institutions. BioNordika Group has […]
INDIANAPOLIS — Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays. The alliance supports plans Roche announced in October 2011 to develop a new line of analyzers for the central coagulation […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
